Effective Suicide Gene Therapy for Leukemia in a Model of Insertional Oncogenesis in Mice
Open Access
- 1 January 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (1) , 183-192
- https://doi.org/10.1038/sj.mt.6300015
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapyProceedings of the National Academy of Sciences, 2006
- In Situ Gene Therapy for Prostate CancerCurrent Gene Therapy, 2005
- Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vectorThe Lancet, 2004
- Gene Therapy Insertional Mutagenesis InsightsScience, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- In situuse of suicide genes for therapy of brain tumoursAnnals of Medicine, 1999
- Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cellsNature Medicine, 1997